Chest Tube Drainage for Hemothorax
(HemoTxRCT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine the best way to treat hemothorax, a condition where blood accumulates in the chest after an injury. Researchers seek to understand whether using a chest tube (thoracostomy tube) to drain the blood is always necessary or if some cases can be managed with careful monitoring alone. Participants will either receive a chest tube or be closely observed without it to evaluate which method is more effective. Individuals who have experienced a blunt chest injury and have blood in their chest detected by a CT scan may be suitable for this study. The results will guide doctors in choosing the best treatment for future patients with similar injuries. As an unphased trial, this study allows participants to contribute to important research that could enhance future treatment options for hemothorax.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that using a chest tube to remove blood from the chest, known as tube thoracostomy, is a common treatment for post-injury chest blood. However, it carries risks. Studies have found complications in 6% to 37% of cases, including procedural injuries and infections.
Some research suggests that smaller tubes can reduce complication risks. These tubes may cause fewer problems and allow quicker drainage. Despite potential risks, chest tubes remain essential for treating chest blood, especially in emergencies.
In summary, while chest tube drainage is effective, it carries risks. The decision to use this treatment often involves weighing benefits against potential complications.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it compares two different approaches for managing hemothorax, which is blood accumulation in the chest cavity. The trial evaluates the effectiveness of using a chest tube to actively drain blood versus expectant management, where no chest tube is used and patients are observed and managed conservatively. The chest tube drain offers a direct method to remove blood from the pleural space, potentially speeding up recovery and reducing complications. This trial could provide insights into which method leads to better patient outcomes and helps refine treatment protocols for hemothorax.
What evidence suggests that this trial's treatments could be effective for hemothorax?
Research shows that chest tubes are commonly used to treat hemothorax, a condition where blood accumulates in the chest after an injury. In this trial, one group of participants will receive a chest tube drain to remove the blood, preventing issues like infection or further harm. However, risks such as injury and infection can occur in up to 22% of patients. Recent evidence suggests that smaller chest tubes might be as effective as larger ones and may cause fewer complications. This method could be less invasive and safer for some patients. Another group in this trial will undergo expectant management, involving standard observation without a chest tube. Overall, chest tube drainage effectively manages hemothorax, but it carries some potential risks.12467
Who Is on the Research Team?
Chad G Ball, MD
Principal Investigator
University of Calgary
Are You a Good Fit for This Trial?
This trial is for adults over 18 with blunt chest injuries and a hemothorax detected by CT scan. It's not for those who are unstable due to the injury, need urgent tube placement, have penetrating injuries, already have a chest tube, were admitted over 24 hours ago, or have severe chest fractures or respiratory distress from the hemothorax.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either chest tube drainage or expectant management for traumatic hemothorax
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Chest tube drain
- Expectant management
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Calgary
Lead Sponsor
Alberta Health services
Collaborator